The 2026 Guide to Medical Device Procurement in South Africa

The South African medical device market is undergoing a profound transformation in 2026. With the healthcare sector valued at an estimated R21–29 billion and relying on imports for approximately 90% of its medical technology, the country presents both significant opportunities and unique challenges for medical device suppliers, manufacturers, and distributors. The South Africa Medical Devices Market reached a value of nearly USD 1.12 billion in 2025 and is projected to grow at a compound annual growth rate of 6.88% through 2032, attaining a value of around USD 1.67 billion. Healthcare spending per capita reached $579.53 in 2025, underscoring the scale and potential of this market.

This guide provides a comprehensive overview of medical device procurement in South Africa—covering regulatory requirements, procurement frameworks, tendering processes, compliance obligations, and emerging trends shaping the industry in 2026. Whether you’re a supplier looking to enter the South African market or a procurement professional navigating the public healthcare system, this guide equips you with the knowledge to succeed.

Part 1: Understanding the Regulatory Landscape — SAHPRA

At the heart of medical device regulation in South Africa lies the South African Health Products Regulatory Authority (SAHPRA), the country’s national regulatory authority responsible for overseeing the safety, quality, and performance of all health products, including medical devices and in vitro diagnostics (IVDs).

SAHPRA’s Mandate and Legal Framework

SAHPRA operates under the Medicines and Related Substances Act (Act 101 of 1965) and is progressively implementing a comprehensive regulatory framework for medical devices. The Authority’s current thinking on safety, quality, and performance is reflected in various guidelines published throughout 2025 and 2026, covering everything from licence applications for listed electronic products to veterinary medical devices.

Key Regulatory Milestones for 2026

The year 2026 marks a critical period for SAHPRA’s regulatory rollout. Several landmark developments include:

• Medical Device Registration Feasibility Study (March 2026): SAHPRA published a comprehensive feasibility study aimed at advancing the implementation of a risk-based regulatory framework for medical devices and IVDs. This study evaluates an effective, risk-based approach for the registration of medical devices, encompassing both locally manufactured and legally imported products.

• ISO 13485 Requirement (Phase 3 — from 1 April 2026): Companies with a valid ISO 13485 certificate that have not yet submitted it to SAHPRA must now submit their existing certificates for verification. This phased approach ensures that establishments operating in South Africa meet internationally recognised quality management standards.

• Guidelines for Licence Applications (February 2026): SAHPRA released a detailed guideline for licence applications for non-ionising radiation medical and non-medical devices classified as listed electronic products, providing clarity on the submission process and documentation requirements.

Device Classification and Registration Pathway

Medical devices in South Africa are classified based on risk, similar to the European Union’s Medical Device Regulation (MDR) framework. Class I (low-risk) devices face the least stringent requirements, while Class III (high-risk) devices—including implantable devices—demand comprehensive clinical evidence. SAHPRA requires documentation covering: detailed device description and specifications, design principles and manufacturing materials, declaration of conformity to applicable standards (including ISO 13485 and ISO 14971), comprehensive risk analysis and management reports, and critical clinical evaluation evidence.

Licensing Requirements

All manufacturers, importers, exporters, and distributors of medical devices must obtain the appropriate establishment licences from SAHPRA. The Amendment of a Medical Device Establishment Licence (document number MD102025/26, Version 1, updated 27 January 2026) outlines procedures for modifying existing licences as business operations change.

Regulatory Technical Forum (RTF)

SAHPRA engages stakeholders through its Regulatory Technical Forum (RTF), with virtual meetings scheduled throughout 2026 to discuss product registration feasibility and related activities. Participation in these forums is essential for staying informed about evolving regulatory expectations.

Part 2: The Procurement Framework — Public vs. Private Sector

South Africa’s medical device procurement landscape is split between the public and private sectors, each operating under distinct frameworks, timelines, and priorities. The government is the primary purchaser of medical devices in South Africa, making public procurement the dominant channel for market entry.

Public Sector Procurement

Structure and Approach

South Africa’s public procurement model is largely structured around multi-year framework tenders, typically running for two to three years depending on therapeutic category. This structure is designed to create price predictability, allow manufacturers to plan production volumes, and stabilise supply over defined periods. In high-burden programmes such as HIV, tuberculosis, and certain chronic diseases, long-term tenders have enabled sustained access and planning certainty.

Procurement Reform and the Public Procurement Act

Public procurement in South Africa is undergoing significant transformation. New procurement legislation provides for the compulsory use of a technology-based procurement system for transparency and efficiency, applicable to all spheres of government. The draft General Public Procurement Regulations, released for comment in May 2026, provide a procurement framework within which procuring institutions may develop and implement their procurement systems, including strategic procurement promotion, procurement methods, evaluation criteria and weighting for bids, bid committee systems and validity periods, security vetting of bidders, contract management requirements, provisions for preferential procurement through set-asides and pre-qualification, and debarment periods and a debarment register.

These regulations are expected to be operationalised once all necessary processes for promulgation are concluded. Comments are due by 15 June 2026, with the regulations taking effect on a date to be determined.

Bid Committee System and Thresholds

A bid committee system governs public sector tenders, with specific thresholds triggering different approval levels. Procurement transactions exceeding R20 million must be notified to the National Department of Health and National Treasury, while variation amounts in excess of thresholds also require notification. The National Treasury has announced four bid windows in the 2026/27 financial year for departments to bid for any infrastructure exceeding R1 billion, with the Department of Health planning to submit 11 bids starting in the July 2026 bid window.

Tender Transition Risks

Tender transition periods can introduce heightened operational complexity and supply chain risk. When a new tender is awarded, manufacturers must align production schedules, validate packaging updates where applicable, and coordinate distribution pipelines to match revised allocation volumes. Even short delays in contract finalisation or onboarding can create temporary supply gaps if outgoing stock is depleted before incoming supply is fully mobilised.

Payment Timelines and Supply Continuity

Predictable and timely payment to contracted suppliers supports production planning and cash flow stability. When payments are processed efficiently, suppliers can maintain buffer stock, prioritise deliveries, and manage working capital requirements effectively. Conversely, delays in invoice processing can introduce financial strain, particularly for smaller manufacturers operating within tighter margins. Strengthening payment governance mechanisms remains a practical lever for improving supply reliability.

Demand Forecasting and Stock Visibility

Accurate forecasting depends on facility-level consumption reporting, provincial aggregation accuracy, and central coordination. Variability in data capture across districts can lead to mismatches between ordered volumes and actual usage patterns. Overstocking in one region alongside shortages in another remains a known operational challenge. Digital stock visibility tools such as the Stock Visibility System (SVS) and depot-level management platforms provide improved insight into facility inventory levels. In 2026, continued integration of digital reporting systems is expected to play a greater role in stabilising supply planning.

National Treasury Tenders

National Treasury manages transversal contracts covering multiple government departments. Current tenders for 2026 include RT24-2026 for the supply, delivery, installation, commissioning and maintenance of hospital furniture and ward requirements for 60 months (closing 25 May 2026), and RT57-2026 for the supply and delivery of various vehicles for 36 months. Bidders must submit their bids online through the e-tender publication portal.

Private Sector Procurement

The private healthcare sector—comprising private hospital groups, ambulatory surgical centres, urology clinics, and other specialised facilities—operates a more commercially driven procurement model. Private procurement focuses on value-based purchasing, clinical outcomes, and total cost of ownership rather than solely on lowest price. Private hospitals typically have established group purchasing organisations (GPOs) or centralised procurement departments that negotiate directly with suppliers.

Private Procurement Priorities

In 2026, private sector procurement is increasingly influenced by:

• Technology adoption: Demand for advanced technologies such as robotics and AI diagnostics is accelerating, driven by Sanlam Private Equity’s recent acquisition of Medhold Group, one of Southern Africa’s largest distributors of medical devices and hospital equipment.

• Patient outcomes: Private hospitals prioritise devices that demonstrate improved clinical outcomes, reduced length of stay, and lower readmission rates.

• Cost transparency: Private payers and medical schemes increasingly demand transparent pricing and demonstrated value for money.

Part 3: Navigating the Tender Process

Participating in South Africa’s public sector tenders requires meticulous preparation, regulatory compliance, and strategic bidding.

Where to Find Tenders

Tenders are published through multiple channels:

• eTenders Portal (www.etenders.gov.za): National Treasury’s central e-tender publication portal where all government tenders must be published.

• Provincial health department websites: Each province (e.g., KwaZulu-Natal Department of Health, Eastern Cape Department of Health) publishes tender awards and current opportunities on its official website.

• Tender bulletin platforms: Commercial platforms such as tenderbulletins.co.za, tenderalerts.co.za, and GlobalTenders aggregate tender opportunities from across the country.

Key Tender Examples in 2026

Recent and current tenders illustrate the range of procurement opportunities:

Tender Reference Description Closing Date

ZNB 9046/2026-H Supply, delivery, installation, commissioning and maintenance of theatre table orthopaedic spinal electronically operated (M38B) for Ngwelezane Hospital (KZN) May 2026

SCMU3-P26/27-0125-PEP Supply and delivery of cardioplegia cannulae at PE Provincial Hospital (Eastern Cape) 19 May 2026

RFQ KZN 017867 Supply and installation of plate centrifuges at NHLS Albert Luthuli Haematology Laboratory 8 April 2026

RT24-2026 Supply, delivery, installation, commissioning and maintenance of hospital furniture and ward requirements to the state for 60 months 25 May 2026

Bid Opening and Submission

Bids must be submitted online through the e-tender publication portal, with bid openings conducted electronically. Bidders who have submitted bids online by the closing date participate in the opening process.

Required Documentation for Bidding

Successful tender participation requires submission of multiple mandatory documents:

• SAHPRA licensing: Valid licensing from SAHPRA to manufacture, import, export, or distribute medical devices is mandatory. A recent tender for disposable safety lancets explicitly required “valid licensing from SAHPRA to manufacture, import, export, or distribute medical devices”.

• Tax clearance certificate: Valid tax clearance certification from SARS (South African Revenue Service) is required for all bidders.

• B-BBEE certificate: An original B-BBEE (Broad-Based Black Economic Empowerment) certificate or certified copy must be submitted. Multiple tenders in 2026 require this documentation, including those for plate centrifuges, blood mixers, microscopes, and RPR rotators.

• Central Supplier Database (CSD) report: A CSD report within the RFQ period is required for most tenders.

• Official quotation and manufacturer’s brochure: Fully completed official quotation and manufacturer’s brochure confirming product specifications.

• Standard bidding documents (SBD): Completed and signed SBD forms, including SBD 4 (Bidders disclosure) and SBD 6.1 (Preference points claim form).

• Local content compliance: Bids must be compliant with the Preferential Procurement Regulations, 2017, including local content, functionality, price and preference, eligibility criteria, and relevant statutory criteria.

B-BBEE and Preferential Procurement

Preferential procurement is a cornerstone of South Africa’s public procurement system. B-BBEE status is a critical scoring criterion in tender evaluations. Submissions must include company profile with B-BBEE status, established presence or support network in the country, device information (intended use, disease area or category), and scalability, cost, and implementation details.

Higher B-BBEE contribution levels receive preference points, making it essential for medical device suppliers to understand their B-BBEE rating and, where possible, partner with B-BBEE-compliant local entities.

Price, Functionality, and Preference Points

Tender evaluation follows a points-based system:

• Price (90 points, or 80 points where functionality is a criterion): Competitive pricing is essential, but not the sole determinant.

• Functionality: For technically complex devices, functionality is evaluated before price consideration. Bidders must demonstrate that their devices meet the specified technical requirements.

• Preference points (10 or 20 points): Awarded based on B-BBEE contribution levels.

• Local content: Priority is given to goods manufactured locally or with specified local content thresholds.

Part 4: Emerging Trends Shaping Medical Device Procurement in 2026

Several transformative trends are reshaping the procurement landscape and creating both opportunities and challenges for medical device suppliers.

National Health Insurance (NHI) Implementation

South Africa’s National Health Insurance (NHI) programme, legislated in 2023 with implementation scheduled to begin in 2026, aims to provide universal healthcare access for all South Africans. The NHI will fundamentally reshape medical device procurement in several ways:

• Centralised purchasing: The NHI Fund will determine the range of products (medicines, devices, etc.) required to deliver benefits and will set prices for those products that any contracted provider will pay to suppliers.

• Expanded addressable market: The NHI aims to universalize healthcare access, potentially expanding the addressable market for medical devices by integrating underserved populations into formal healthcare systems.

• Market growth acceleration: The South African medical device market is projected to reach USD 3.94 billion by 2029, driven by NHI implementation, technological adoption, and regional trade integration.

• Pricing pressures: The NHI Fund will set prices for reimbursed products, potentially compressing margins for suppliers.

Localisation and the Medical Technology Master Plan

Localisation is a priority for South Africa. The Department of Trade, Industry and Competition (DTIC) has developed a Medical Technology Master Plan aimed at localising medical device production, reducing reliance on imports, strengthening the industrial base, and improving healthcare infrastructure and resilience. The Master Plan seeks to:

• Reduce dependence on imports, with approximately 90% of medical technology currently imported.

• Grow local medtech exports, fostering a more prosperous economy.

• Support local innovators and manufacturers of proudly South African medical technologies.

• Champion small, medium, and micro-enterprises (SMMEs) in the medtech sector.

• Address the unique challenges of SMMEs, including resource and capacity constraints.

A noteworthy example of local innovation is VIVA Medical, which locally produces infusion administration sets and needle-free infusion devices in South Africa—the continent’s first such device. The company is launching Africa’s first locally developed needle-free device, named VIVASite™.

The Problem of Non-Functional Equipment

A critical driver behind the localisation push is the unacceptable rate of non-functional medical equipment in public health facilities. The World Health Organization estimates that 50–80% of medical equipment in under-resourced health systems is non-functional at any given time. More specifically, between 40% and 70% of donated equipment remains unused due to poor contextual fit, inadequate planning, insufficient training, and a lack of maintenance capacity—effectively creating “medical device graveyards”. Imported equipment that cannot be maintained or repaired undermines the entire purpose of procurement.

Import Duties and Trade Agreements

Understanding import duties is essential for medical device suppliers, as most devices are imported into South Africa.

Standard Import Duty Rates (2026):

Product Category HS Chapter Typical Duty Rate

Certain medicines and medical equipment — 0%

Electronics (computers, phones) 84–85 0–5%

Machinery and equipment 84 0–10%

Chemicals 28–38 0–15%

Plastics and rubber 39–40 5–20%

Duties are generally calculated on the Free on Board (FOB) value of goods, with a standard VAT of 15% applied to the Added Tax Value (ATV).

China-Africa Zero Tariff Policy (Effective 1 May 2026):

A significant development for 2026 is China’s implementation of a 100% tariff line zero-tariff policy for medical devices exported to 53 African countries with which China has diplomatic relations, including South Africa, Nigeria, Kenya, and Egypt. This eliminates the need for bilateral negotiations and directly reduces product landed costs, particularly beneficial for consumables and basic equipment exports.

However, compliance remains critical. South Africa requires SAHPRA registration, which must be completed before shipment—it cannot be done after arrival in port.

AfCFTA and Intra-African Trade:

The African Continental Free Trade Area (AfCFTA), connecting 54 countries with 1.3 billion people and a combined GDP of $3.4 trillion, is progressively reducing duties on intra-African trade. The pharmaceutical and medical device sector is identified as a critical priority, particularly in light of lessons learned during the COVID-19 pandemic, which exposed Africa’s dependence on imported medicines and medical supplies. The AfCFTA framework is expected to support the growth of regional pharmaceutical manufacturing hubs and facilitate cross-border movement of medicines and devices.

However, significant challenges remain. South African medical device manufacturers face unaligned standards verification systems across African countries, logistical costs, and tariff and tax breaks that are out of sync with intra-regional trade principles.

Technological Advancements and Digital Health

South Africa’s medical technology landscape is embracing innovation:

• Robotics and AI diagnostics: Sanlam Private Equity’s investment in Medhold Group will accelerate the adoption of advanced technologies such as robotics and AI diagnostics.

• Telemedicine and point-of-care testing: The Department of Health is actively assessing the expansion of portable health technology and point-of-care testing devices, especially at primary healthcare facilities, to increase equitable access to healthcare without compromising quality.

• Digital stock visibility systems: Systems such as the Stock Visibility System (SVS) and depot-level management platforms are being integrated to provide real-time insight into facility inventory levels, enabling earlier identification of low-stock warnings and redistribution opportunities.

• Artificial intelligence: A key trend in the South African medical device market is the increased use of artificial intelligence and machine learning across various device categories.

Global Supply Chain Volatility

Many medical devices procured through national tenders rely on imported components or finished products. International shipping delays, raw material shortages, and currency fluctuations can affect supplier performance even when local procurement processes are functioning efficiently. Manufacturers and distributors are increasingly building contingency buffers and diversifying sourcing strategies to mitigate these risks.

Environmental, Social, and Governance (ESG) Considerations

ESG factors are gaining prominence in procurement decisions. The draft Public Procurement Regulations require declarations of interest, codes of conduct for officials, and debarment registers for non-compliant suppliers. Environmental sustainability in device design and packaging, ethical supply chain practices, and social impact through B-BBEE and local manufacturing are becoming differentiators.

Part 5: Practical Steps for Medical Device Suppliers

For suppliers seeking to enter or expand in the South African medical device market, the following roadmap provides a strategic pathway.

Step 1: Secure SAHPRA Compliance

Before any procurement activity, secure the necessary SAHPRA establishment licences and, where applicable, product registrations:

• Obtain a valid SAHPRA establishment licence for your activities (manufacturing, importing, exporting, or distribution).

• For higher-risk devices, pursue product registration through SAHPRA’s risk-based pathway.

• Ensure ISO 13485 certification is current and submitted to SAHPRA for verification.

• Engage a local South African representative if your company does not have a local presence.

Step 2: Register on Central Supplier Database (CSD)

The Central Supplier Database is the mandatory entry point for doing business with the South African government. Complete CSD registration with all required documentation, including tax clearance, B-BBEE certificate, and company registration details.

Step 3: Understand B-BBEE Requirements

Assess your B-BBEE status and develop a strategy to improve your score where possible. Options include partnering with B-BBEE-compliant local distributors, establishing joint ventures or consortia with historically disadvantaged enterprises, subcontracting a percentage of contract value to B-BBEE entities, and obtaining a verified B-BBEE certificate.

Step 4: Build Local Presence or Partnerships

Having an established presence or support network in South Africa is increasingly viewed favourably in tender evaluations. Consider engaging a local distributor or agent with established relationships with provincial health departments and National Treasury. Attending Africa Health (the premier medical exhibition in South Africa) provides opportunities to connect directly with local hospital procurement, chain medical institutions, local agents, and cross-border wholesalers.

Step 5: Monitor Tender Opportunities

Establish a systematic approach to monitoring tender opportunities:

• Subscribe to eTenders Portal alerts for relevant categories.

• Monitor provincial health department websites (KZN, Eastern Cape, Western Cape, etc.).

• Utilise commercial tender alert services.

• Attend pre-bid briefings and regulatory forums.

Step 6: Prepare Competitive Bids

Invest in high-quality bid preparation:

• Ensure all mandatory documentation is current and complete.

• Price competitively while maintaining quality.

• Clearly articulate functional advantages of your devices.

• Demonstrate your B-BBEE contribution.

• Where applicable, highlight local content and local manufacturing partnerships.

• Include comprehensive service, maintenance, and training provisions.

Step 7: Plan for Long-term Contract Management

Winning a tender is only the beginning. Successful contract management requires robust supply chain capabilities to ensure reliable delivery, maintenance and service support for installed equipment, training for healthcare personnel, compliance with contract performance metrics, and proactive communication with procurement officials.

Part 6: Challenges to Anticipate and Mitigate

The South African medical device procurement landscape presents several challenges that suppliers must navigate.

Irregular Expenditure and Internal Controls

Irregular expenditure results from inadequate and weak internal controls in government institutions. The Auditor-General’s audit reports document significant irregular expenditure across government institutions. Bidders should be aware that procurement processes are subject to intense scrutiny and potential legal challenges.

Delay in Procurement Reform Implementation

While new procurement legislation is at an advanced stage, the current regulatory framework (PFMA, MFMA, PPPFA) continues to operate pending finalisation. The delay in finalisation has no direct bearing on irregular expenditure but creates uncertainty for long-term planning. National Treasury continues to work with the Auditor-General to monitor and support government institutions in improving internal controls.

Tender Invalidations and Litigation Risk

Tender processes are frequently challenged, leading to invalidations, litigation, and contingent liabilities. Suppliers should ensure impeccable compliance with all procedural requirements to avoid being excluded on technical grounds.

Payment Delays

Delays in invoice processing can introduce financial strain, particularly for smaller manufacturers operating within tighter margins. Suppliers should build sufficient working capital reserves to absorb potential payment delays and maintain buffer stock to ensure supply continuity.

Infrastructure Gaps

The Department of Health submitted a request for funding to National Treasury for Section 16 funding, but the funding period ended in March 2026 and was not added to budget baselines for the 2026/27 financial year. Infrastructure constraints at public health facilities can limit the effective deployment of new medical technologies.

Conclusion

Medical device procurement in South Africa in 2026 is a dynamic and evolving landscape. The confluence of SAHPRA’s maturing regulatory framework, procurement reform through new public procurement legislation, the impending implementation of NHI, and a strategic push toward localisation is reshaping how medical devices are bought, sold, and deployed.

Success in this market demands a comprehensive understanding of the regulatory environment, meticulous preparation for tender processes, meaningful B-BBEE compliance, and a long-term commitment to partnership with South African stakeholders. For suppliers willing to invest in compliance, build local relationships, and demonstrate value beyond price, the South African medical device market offers substantial opportunities in 2026 and beyond.

The market is projected to grow from USD 1.12 billion in 2025 to USD 1.67 billion in 2032, driven by rising healthcare requirements, increasing chronic illnesses, mounting demand for cost-effective solutions, and the transformative impact of NHI. At the same time, the high rate of non-functional equipment in public facilities underscores the urgent need for procurement approaches that prioritise not just initial purchase price, but long-term sustainability, local serviceability, and contextual fit.

As South Africa works to address its quadruple burden of disease and achieve universal health coverage, medical devices will play an increasingly central role. Suppliers that align their strategies with South Africa’s regulatory, procurement, and localisation priorities will be well-positioned to contribute to—and benefit from—this transformation.